Neuropeptide Y-Graphene Oxide Complexes Inhibit Amygdala NPY-Receptor Expressing Glutamatergic Pathways and...

Area of Science:

• Neuroscience
• Materials Science
• Nanotechnology

Background:

• Modulating brain circuits is crucial for treating neurological diseases.
• Graphene-based materials (GBMs) offer potential for targeted therapeutic interventions.
• Graphene oxide (GO) nanosheets can be engineered for selective drug delivery to neural cells.

Purpose of the Study:

• To engineer GO:neuropeptide Y (NPY) for complexing and transporting NPY.
• To investigate the activity of GO:NPY in regulating excitatory neurotransmission in NPY-positive synaptic pathways.
• To assess the efficacy of GO:NPY in modulating fear memory responses in an anxiety disorder model.

Main Methods:

• In vitro studies to assess GO:NPY's effect on glutamate release and synaptic enhancement via NPY receptors.
• In vivo administration of GO:NPY into the amygdala of rats with anxiety disorder.
• Evaluation of contextual fear memory responses following GO:NPY injection.

Main Results:

• In vitro, GO:NPY specifically inhibited glutamate release and synaptic enhancement through NPY receptors.
• In a rat model, amygdala injection of GO:NPY suppressed contextual fear memory.
• The observed effects were mediated by the activation of NPY receptors in specific synaptic pathways.

Conclusions:

• Engineered GO:NPY effectively modulates excitatory neurotransmission and fear memory.
• This GBM-based nanoplatform demonstrates potential for targeted co-delivery of therapeutics.
• GO:NPY offers a promising strategy for treating neurological conditions requiring specific synaptic pathway intervention.